Filing Details
- Accession Number:
- 0000902664-24-001290
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-08 16:32:33
- Reporting Period:
- 2024-02-06
- Accepted Time:
- 2024-02-08 16:32:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1999480 | Alto Neuroscience Inc. | ANRO | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1558858 | Alpha Wave Global, Lp | 667 Madison Avenue 19Th Floor New York NY 10065 | No | No | Yes | No | |
2007422 | Alpha Wave Ventures Gp, Ltd | 667 Madison Ave. 19Th Floor New York NY 10065 | No | No | Yes | No | |
2009522 | Ltd Rsc Holding Lunate | Unit 1, Floor 12, Al Maryah Tower Abu Dhabi Global Market Square Al Maryah Island, Abu Dhabi C0 00000 | No | No | Yes | No | |
2009884 | Chimera Investment Llc | Office 410, Royal Group Hdqrtrs Building Khalifa Park Area Abu Dhabi C0 00000 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-06 | 1,962,995 | $0.00 | 1,962,995 | No | 4 | C | Indirect | See footnotes |
Common Stock | Acquisiton | 2024-02-06 | 1,144,762 | $0.00 | 3,107,757 | No | 4 | C | Indirect | See footnotes |
Common Stock | Acquisiton | 2024-02-06 | 600,000 | $16.00 | 3,707,757 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See footnotes |
No | 4 | C | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Convertible Preferred Stock (Series B Preferred) | Disposition | 2024-02-06 | 1,962,995 | $0.00 | 1,962,995 | $0.00 |
Common Stock | Series C Convertible Preferred Stock (Series C Preferred) | Disposition | 2024-02-06 | 1,144,763 | $0.00 | 1,144,763 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Immediately prior to the closing of the Issuer's initial public offering, each share of Series B Preferred Stock automatically converted into shares of common stock on a 2.1226069 for 1 basis into the number of shares of common stock shown in column 3 and had no expiration date.
- Immediately prior to the closing of the Issuer's initial public offering, each share of Series C Preferred Stock automatically converted into shares of common stock on a 2.2241 for 1 basis into the number of shares of common stock shown in column 3 and had no expiration date.
- Securities held by Alpha Wave Ventures II, LP ("Alpha Wave Ventures"). Alpha Wave Ventures GP, Ltd ("Alpha Wave Ventures GP") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP ("Alpha Wave") and Lunate Holding RSC LTD ("Lunate"). Lunate is a subsidiary of Chimera Investment LLC ("Chimera," together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the "Reporting Persons"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors.
- For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose.